I.V. administration of L-GnRH-PE66 efficiently inhibits growth of colon adenocarcinoma xenografts in nude mice

International Journal of Cancer

Volumn 92, Issue 2, 2001, Pages 263-268

  Ben Yehudah, Ahmi ^a   Prus, Diana ^a   Lorberboum Galski, Haya ^a,b  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Chimeric proteins; Colon adenocarcinoma; I.v. injections; L GnRH PE66

Indexed keywords

CHIMERIC PROTEIN; GONADORELIN; GONADORELIN PE66; PSEUDOMONAS EXOTOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; COLON ADENOCARCINOMA; CYTOTOXICITY TEST; FEMALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ADP RIBOSE TRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; COLONIC NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; EXOTOXINS; GONADOTROPIN-RELEASING HORMONE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; MICE; MICE, NUDE; RECOMBINANT FUSION PROTEINS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035871996     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1185>3.0.CO;2-E     Document Type: Article

References (22)

1. Adenocarcinoma cells are targeted by the new GnRH-PE66 chimeric toxin through specific gonadotropin-releasing hormone binding sites
2. Linker-based GnRH-PE chimeric proteins inhibit cancer growth in nude mice
3. Evolutionary aspects of gonadotropin-releasing hormone and its receptor
4. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin
5. Recombinant toxins as novel therapeutic agents
6. Cardiac allograft survival in mice treated with IL-2-PE40
7. Chimeric cytotoxin IL2-PE40 delays and mitigates adjuvant-induced arthritis in rats
8. Pharmacokinetics and antitumor activity of a bivalent disulfide-stabilized Fv immunotoxin with improved antigen binding to erbB2
9. Toxicology and pharmacokinetics of DTGM, a fusion toxin consisting of a truncated diphtheria toxin (DT388) linked to human granutocyte-macrophage colony-stimulating factor, in cynomolgus monkeys
10. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: Evidence for an autocrine-inhibitory LHRH loop
11. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma
12. The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: Messenger ribonucleic acid expression, molecular size, and signal transduction pathway
13. Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues
14. Current and potential application of GnRH antagonist in gynecologic practice
15. Development of GnRH antagonist for prostate cancer: New approaches for treatment
16. Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix
17. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor
18. Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata
19. Gonadotropin-releasing hormone specific binding sites in normal and malignant renal tissue
20. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists
21. Adenosine 3′,5′-monophosphate, prostaglandins, and epinephrine stimulate the secretion of immunoreactive gonadotropin-releasing hormone from cultured human placental cells
22. Tissue-specific pattern of variant transcripts of the human gonadotropin-releasing hormone receptor gene